Mid-term results of a randomized trial of tricuspid annuloplasty for less-than-severe functional tricuspid regurgitation at the time of mitral valve surgery† | Zendy

Matteo Pettinari | Zendy; Laurent de Kerchove | Zendy; Siham Lazam | Zendy; Agnès Pasquet | Zendy; Bernhard Gerber | Zendy; JeanLouis Vanoverschelde | Zendy; Gébrine Elkhoury | Zendy

Open Access

Mid-term results of a randomized trial of tricuspid annuloplasty for less-than-severe functional tricuspid regurgitation at the time of mitral valve surgery†

Author(s) -

Matteo Pettinari,

Laurent de Kerchove,

Siham Lazam,

Agnès Pasquet,

Bernhard Gerber,

JeanLouis Vanoverschelde,

Gébrine Elkhoury

Publication year - 2018

Publication title -

european journal of cardio-thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.303

H-Index - 133

eISSN - 1873-734X

pISSN - 1010-7940

DOI - 10.1093/ejcts/ezy378

Subject(s) - medicine , cardiology , ejection fraction , tricuspid valve , mitral valve , mitral regurgitation , randomized controlled trial , mitral valve replacement , tricuspid valve insufficiency , surgery , heart failure

The optimal management of functional tricuspid regurgitation (FTR) in the setting of mitral valve operations remains controversial. The current practice is both centre specific and surgeon specific with guidelines based on non-randomized data. A prospective randomized trial was performed to evaluate the worth of less-than-severe FTR repair during mitral valve procedures.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research